Live from IMS 2026: EXCALIBER-RRMM: First Phase 3 CELMoD Data With MRD-Negative CR as a Dual...
2) This program, intended for #HCPs, is supported by an independent educational grant from Bristol Myers Squibb. Follow this 🧵for 🆓1.0h CE/#CME! Statement o ...
oncologytweetorials-ce.com